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Background: Because more patients reach adulthood, new questions as ‘‘what about having a child and/or paternity responsibility?’’ arose.
Method: We performed a retrospective investigation based on the French CF registry. The context of the paternity and the health status of
fathers were recorded. A comparison with clinical status of non-father patients and a compilation of follow-up data to evaluate its impact
were done.
Results: Forty-eight men had 69 children. One fourth was said to be natural conceptions, 69% needed assisted reproduction techniques. No
child had CF. Clinical status of men was satisfactory: mean BMI was 20.9 kg/m2 and mean FEV1 and FVC were 50.5% and 69.2% of
predicted, respectively. When matched to CF non-fathers, few significant differences appeared. More non-fathers were F508del/F508del
( p =0.03). Fathers’ sputum cultures were positive for non-Pseudomonas aeruginosa strain ( p =0.05), including Staphylococcus aureus
( p =0.01). Mean age at diagnosis was higher, and based on minor evidence of sterility as first symptom leading to the diagnosis of CF
( p =0.01) or aspergillosis ( p =0.03). The 3-year follow-up showed no degradation of the clinical status.
Conclusion: Men having paternity responsibility over children did not differ from the CF male population and neither did it seem to have an
impact on the disease course.
D 2006 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Cystic fibrosis; Paternity; Clinical status; Clinical impact1. Introduction
Cystic fibrosis (CF) is the most common life-limiting
genetic disorder in white Caucasians. It is due to a defect in
the cystic fibrosis gene encoding for cystic fibrosis
conductance regulator (CFTR) protein. It leads to a chronic
bronchial infection and obstructive pulmonary disease1569-1993/$ - see front matter D 2006 European Cystic Fibrosis Society. Publish
doi:10.1016/j.jcf.2006.03.004
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E-mail address: marc.debraekeleer@univ-brest.fr (M. De Braekeleer).associated with various extra-respiratory symptoms as
pancreatic insufficiency, distal intestinal obstructive syn-
drome, liver cirrhosis, diabetes and others.
The combination of early diagnosis and adjusted care
management had led to higher life expectancy. Thus, more
and more CF patients reach adulthood. In France, the mean
age of patients was 12.2 years in 1994 (median: 11 years),
whereas it was 15.5 years in 2002 (median: 14 years).
Moreover, mean life expectancy at birth was 38.8 years for
the 1999–2001 period [1,2]. In 1994, 20.8% of the
registered patients in the French CF registry were 18 years
old and over vs. more than one third (37.1%) in 2002 [1,2].
Because of this increasing male adult population, new
questions have to be faced. Two of these are ‘‘what about
having a child and/or paternity responsibility?’’ and ‘‘what is5 (2006) 215 – 221ed by Elsevier B.V. All rights reserved.
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course and management?’’ Almost 98% of CF males
patients are infertile [3]. This infertility is the consequence
of congenital bilateral absence of the vas deferens (CBAVD)
and/or of absence of seminal vesicles; therefore, spermato-
zoa cannot be ejaculated [4,5]. Indeed, CFTR mutations
may interfere at an early embryonic stage, when the Wolfian
duct is differentiated into the scrotal vas and distal
epididymis. The lack of secretion may lead to the
interruption of the development and agenesis of the deferens
[6]. These hypotheses are coherent with observations
reported on adults and children [4,7].
Male infertility may be a clue to diagnose CF in adults,
using a semen analysis to establish their fertility status [8].
On the other hand, CBAVD may also be associated with
infertility in males without classical CF. One CFTR gene
mutation and/or variant and a positive sweat test can be found
[9–11]. This physiopathology was not considered in the
present study. Assisted reproductive techniques (ART) allow
men with CF to have children despite effective infertility.
For many years artificial insemination with a sperm
donor (AID) was the only alternative to men infertility.
Since the beginning of the 1990s, in vitro fertilisation using
microsurgical sperm aspiration coupled with intra-cytoplas-
mic spermatozoan injection (ICSI) offers a new opportunity
to have a child [12].2. Materials and methods
Since 1992, the French CF registry has collected and
analysed data from most of the CF patients regularly seen in
CF care centres in France. It is based on a yearly
questionnaire collecting demographic, clinical and social
data for every CF patient seen during that period. Consent
from the patients, or from the parents if minor, to perform
analyses with the collected data was obtained when the pa-
tient was first integrated in the registry. Thematic question-
naires have been implemented, as tools to study specific
aspects of CF (pregnancies, Burkholderia cepacia, etc.).
The thematic database on paternity was established in
2003. Data are requested on men’s birth date, date at
diagnosis, genotype, date of death, if applicable. Modalities
of the paternities were also registered: natural conception
(NC), artificial insemination with a sperm donor (AID),
intra-cytoplasmic spermatozoan injection (ICSI), or adop-
tion (AD). Genetic counselling prior to the conception was
recorded. Data on each child (date of birth, sex, having CF
or not, single or twin birth) were also asked.
Previous to continuous recording on paternities, we
performed a retrospective study. All participating CF centres
to the French CF registry were asked to notify, using the
same questionnaire, all men who had had a child, whatever
the year of birth and the modality of paternity.
The health status of the fathers who attended a CF centre
in 2002 was evaluated using the yearly collected data fromthe French CF registry. Variables included were BMI
expressed as kg/m2, and FVC, FEV1 as % of predicted
value. Measures from those who died or received trans-
plantation were excluded. Results of sputum cultures were
gathered into two categories: ‘‘Pseudomonas aeruginosa
family’’ (including P. aeruginosa, Stenotrophomonas mal-
tophilia, B. cepacia), and ‘‘non-P. aeruginosa family’’
(including Haemophilus influenzae, Staphylococcus aureus,
Aspergillus, and Candida). Occurrence of liver cirrhosis,
diabetes and treatment (IV-ATB), mean number of courses
for those having at least one enzymatic supplementation as
indicator of pancreatic insufficiency were also taken into
account. Those fathers attending were compared to non-
father CF patients. We matched one father to two non-
fathers, in order to measure differences that might exist
within a ‘‘medium’’ population. It was composed of males
without a child, of similar age (S.D.=2 years), having a
fully identified genotype, and attending, at least for the
youngest adults, the same CF care network. This criterion
was not used for patients over 33 years in 2002, because of
the small size of the CF population. Indeed, in the 2002
enquiry, only 323 males could be possible pairs, but only 78
were 33 years or older [2]. Moreover, few centres managed
old patients and practitioners tended to have similar policies.
Extracted variables were similar to those previously
considered. We added evidence leading to diagnosis
(meconium ileus, malnutrition, diarrhoea, respiratory prob-
lems, nasal polyposis, and sterility as first symptom leading
to the diagnosis of CF). Genotypes were divided into 6
groups (F508del/F508del, F508del/other, F508del/un-
known, other/other, other/unknown and unknown/un-
known). They were also classified according to the
disease expression: severe (2 severe mutations), mild
(severe/mild or mild/mild), or unknown (at least one
unknown mutation, or mutation for which expression was
not measurable). The pancreatic status was elected as the
classification criterion.
Finally, we compiled a 3-year follow-up data to measure
the impact of the presence of a child at home on the clinical
status. The follow-up was carried out during 3 years for
children born in 1999 or 2000, 2 years for those born in
2001, and 1 year for these born in 2002. Selected data were
BMI, FEV1 and FVC, results of sputum cultures, as
previously described. Frequency of outpatient visits, daily
hospitalisations, IV-ATB treatment, enzymatic supplemen-
tation, and liver cirrhosis, diabetes, transplantation or death
were also registered.3. Analysis
Continuous data were presented as means with the
indication of standard deviation (S.D.) and median value.
Comparisons were performed using a two-tailed t-test for
continuous variables. Categorical variables were presented
as the number of positive events. They were compared using
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Fig. 1. Distribution of the number of births registered by period and mode
of procreation.4. Results
Eighty-three centres were contacted. All CF care centres
having patients over 18 years (n =71) participated to the
present study, including the most important ones. Only 12 of
them (17%) reported men having children.
Sixty-nine paternities were recorded for 48 men (Table
1). Only 3 births occurring in the 1960–1969 and 1970–
1979 periods, respectively (0.3 per year meanly), have
been reported. Thirteen occurred in the 1980s (1.3 yearly)
and 28 in the 1990s (2.9 per year). Between 2000 and
2003, 22 births have been notified (5.5 yearly). Fathers
were meanly aged of 37.7 years, and their mean age at
diagnosis was 19.7 years. For 13 men, diagnosis occurred
when their 24 children were meanly aged of 8.9 years. In
2003, 6 men (12.5%) were dead (mean age 41.3 years);
thus, 8 children became fatherless at the mean age of
10.2 years.
One fourth of the paternities (n =18) was said to be
natural conception ones, 35% (n =24) had required AID,
34% (n =23) needed ICSI, and 6% (n =4) were adoptions.
Paternities registered in the 1960s or 1970s were natural or
AID conceptions. Adoption was first mentioned in the late
1980s, whereas ICSI was first used in the late 1990s. Since
1995, 23 ICSI have been performed, including 8 during the
1990s and 15 in the 2000–2003 period (Fig. 1).Table 1
Clinical description of CF men having children
Fathers (number) 48
Mean ageTS.D. (years) 37.7T8.2
Mean age at diagnosisTS.D. (years) 19.7T17.8
Alive in 2003 (number) [%] 42 [87.5%]
F508del/F508del (number) [%] 13 [27.1%]
Severe genotype (severe/severe) (number) [%] 24 [50.0%]
Mild genotype (severe/mild or mild/mild) (number) [%] 11 [22.9%]
Unknown severity (at least one unknown mutation)
(number) [%]
13 [27.1%]
Natural conception (number) [%] 18 [26.1%]
AID conception (number) [%] 24 [34.8%]
ICSI conception (number) [%] 23 [33.3%]
Adoption (number) [%] 4 [5.8%]
Modalities of conception
F508del/F508del (natural/AID/ICSI/adoption) 1/2/8/2
Severe genotype (natural/AID/ICSI/adoption) 3/8/11/2
Mild genotype (natural/AID/ICSI/adoption) 2/5/3/1
Unknown severity (natural/AID/ICSI/adoption) 4/3/5/1
Age at first birthTS.D. (years) 30.7T5.2
Children (number) 69
Females [%] 59
Males [%] 39
Twin pairs (number) 7Thirteen men were F508del homozygotes and 21
compound heterozygotes F508del/other mutation. Ten
F508del/F508del used AID or ICSI and only one fathered
naturally. Only 4 F508del/other mutation fathered naturally;
they carried R117H, G542X, E60X and 2789+5GYA
alleles. Twenty-four patients had a severe disease expression
genotype, according to pancreatic status. Eleven had a mild
genotype and 13 a non-classified genotype.
Only one natural conception over 13 was reported from a
F508del/F508del father, whereas 10 required AID or ICSI
(76.9%). Men bearing a severe disease expression genotype
had few natural conceptions (3/24, i.e., 12.5%), whereas
those having mild or unknown genotype had, respectively,
2/11 (18.2%) and 4/13 (30.8%) naturally fathered. On the
other hand, the frequency of use of ART decrease with the
degree of disease severity: 11 of the 24 men with severe
genotype (79.2%), but only 8 of the 11 with mild one, and
8 of those with unknown expression (61.5%) required it.
The mean age at the first naturally conceived birth was
28.1 years (S.D.=6.1), whereas it was 31.3 years (S.D.=
4.9) when ICSI was required. Men choosing adoption were
even older: 37.8 years (S.D.=7.1). Whatever the modality
of conception, 33 men had only one child, 13 had 2 and 4
had 3. Each CF patient had 2 children when conceived
naturally. One man had meanly 1.5, 1.2, and 1.0 children
using AID, ICSI, and AD, respectively. The medium-size
family was 1.4 children.
Fifty-two percent of the CF men received genetic
counselling. No child had CF. Twenty percent of births
(n =14) were twins. One pair of twins has been NC
conceived, 2 through AID and 4 via ICSI. Three of them
were single-sex pairs.
Forty of the 48 men having responsibility over children
attended a CF care centre in 2002. Six were dead, 1 was lost
to follow-up, and 1 moved to North America. The mean age
of those seen in 2002 was 37.7 years (S.D.=1.5), the
median value was 36.0 years. Their mean age at diagnosis
was 19.1 years (S.D.=18.8), and half of them were
diagnosed before the age of 10. Their mean BMI was
20.9 kg/m2 (S.D.=3.05), even if 7 of them had value below
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and FVC were, respectively, 50.5% and 69.2% of predicted
values (median 48.5% and 69.7% of expected), excluding
those who died or were transplanted. Four men had a FVC
below 30% predicted, 2 of them died in 2002. Thirteen men
had an FEV1 below 30% expected, including those 2 who
died and one enrolled on a waiting list for lung transplant.
Twenty-six fathers had at least one ‘‘P. aeruginosa family’’
strain, and 13 had also non-Pseudomonas strains in sputum
cultures. Compilation of clinical events showed that none
had liver cirrhosis, 18.4% had diabetes. IVATB courses were
required for 22 of the 40 men with the mean number of
courses being 1.95 per patient. Finally, 29 (72.5%) required
pancreatic enzymatic supplementation.
Thirty-four fathers were matched to 68 non-fathers. The
mean ages in 2002 were similar (35.7 years vs. 35.0).
Results are summarised in Table 2. Mean age at time of
diagnosis was 5 years higher (15.3 vs. 10.2 years NS) in the
fathers group than in the childless one. No significant
difference was observed in the occurrence of meconium
ileus, diarrhoea, or respiratory disease, as evidence to
diagnosis. Malnutrition was 2 times less frequent among
the CF fathers than among their matched pairs (NS). On the
other hand, men having fathered had about 6 times more
frequently nasal polyposis (8.8% vs. 1.5% NS) and a greaterTable 2
Description and comparison of clinical data for men having children with matche
Fathers (nu
Number 34
Mean age in 2002TS.D. [median] (years) 35.67T7.44
Range [24.0–59.0
Mean age at diagnosisTS.D. [median](years) 15.32T16.0
Clinical evidences
Meconium ileus 2/34
Malnutrition 4/34
Diarrhoea 8/34
Respiratory problems 18/34
Sterility as symptom at diagnosis 7/34
F508del/F508del 9/34
Died 1
Lung transplantation 1
Enrolled on a waiting list in 2002 1
BMITS.D. (kg/m2) [median]a 21.16T2.94
Range [15.60–29
FEV1TS.D. (% pred) [median]
a 50.24T26.9
Range [13.53–11
FVCTS.D. (% pred) [median]a 69.47T24.7
Range [20.88–12
P. aeruginosa family strains (positive culture) 23/31
Non-P. aeruginosa family strains (positive culture) 26/31
Including S. aureus 20/31
Liver cirrhosis 0/33
Diabetes 7/33
Aspergillosis 8/33
IV-ATB courses (nr) 19/34
Mean number of coursesTS.D. 2.06T1.60
Pancreatic enzymatic supplementation 26/34
a Excluding patients who died during the study or had received transplantationpropensity of being diagnosed during a consultation for
difficulty to procreate ( p =0.012). More F508del/F508del
patients were identified in the non-father group than in the
father one (26.4% vs. 48.5% p =0.03). Anthropometrical
measurements showed no differences between both groups.
Mean FVC and FEV1, despite being slightly higher in the
group of men with children, did not significantly vary. No
significant difference in the frequency of occurrence of ‘‘P.
aeruginosa family’’ strains was found, but it was in the
‘‘non-P. aeruginosa.’’ Indeed, 83.8% of the CF male
patients having at least one child had positive cultures but
64.5% of the childless men ( p =0.05). The highest
difference was observed in the occurrence of S. aureus:
64.5% of the fathers vs. only 37.1% of the non-fathers
( p =0.012). Frequencies of liver cirrhosis and diabetes were
similar in both groups. A significant difference was
observed in the occurrence of aspergillosis: 25% of men
with children vs. 8.8% of the non-fathers ( p =0.036). IV-
ATB treatment and pancreatic enzyme supplementation
were required in both populations in similar proportions.
The 3-year follow-up showed no clinical deterioration
during the period following the paternity. Mean BMI, FEV1,
and FVC remained stable, as well as the results of sputum
cultures. Only the number of outpatient visits at the CF care
centre increased from 2.9 to 4.5 per year (NS).d-paired CF patients without children (NS=not statistically significant)
mber) Non-fathers (number) P
68
[34.0] 34.99T7.50 [34.0] NS
] [23.0–60.0]
8 [6.5] 10.17T13.95 [3.0] NS
1/66 NS
17/66 NS
24/66 NS
39/66 NS
3/66 0.012
33/68 0.033
2 NS
1 NS
4 NS
[20.6] 20.81T3.49 [20.9] NS
.41] [13.73–30.42]
1 [48.4] 47.11T26.85 [38.3] NS
9.43] [16.19–114.11]
9 [69.7] 64.70T22.67 [61.2] NS
1.79] [24.79–110.59]
51/62 NS
40/62 0.054
23/62 0.012
6/68 NS
17/68 NS
6/68 0.036
40/68 NS
(17) 2.43T1.45 NS
55/68 NS
.
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We compiled data on 48 CF males having fathered before
2004. One fourth of the paternities was said to be natural
conceptions, and 69% needed assistance to procreation. The
mean age of the father at the time of the study was 37.7
years (S.D.=8.2), and the mean age at first birth, whatever
the modality of procreation, was 30.7T5.2 years. Twenty-
four had a severe disease expression genotype, and 11 a
mild genotype.
The number of men registered as having children
whatever the modality of procreation has increased since
1960. The number of natural conceptions or adoptions
remained stable all over the studied period. Most of the
procreations using ICSI occurred in the last 10 years and
tended to substitute for AID (Fig. 1). Indeed, for many
years, AID was the only alternative to male infertility. Since
the beginning of the 1990s, in vitro fertilisation using
microsurgical sperm aspiration coupled with ICSI offers a
new opportunity to have a child for CF men. Hubert et al.
[14] noticed that only 2 of the 25 men who asked for ART
first chose AID, vs. 23 who chose ICSI. Of the 10 couples
who had no child with ICSI, two chose AID as a second
option [14].
The comparison between men having children and those
without showed that both populations were closed. Nutri-
tional and respiratory status of French adults were close to
those calculated in the present study. Dray et al. measured in
an adult population meanly aged of 28.8 years, a mean BMI
equal to 19.1 kg/m2 and that mean FVC was 61.9% of
predicted (S.D. = 23.5) and 47.1% of predicted (S.D. =
25.5) for FEV1.[13]. Another study performed on patients
over 30 years, but diagnosed before the age of 5, found a
mean BMI of 19.5 kg/m2 in both groups, a mean FVC of
68% and 70%, respectively, and a mean FEV1 being 49%
and 54% [15].
Despite the overall ‘‘good’’ clinical status, we observed
that 8 children became fatherless at a mean age of 10.2Table 3
Synthesis of case reports on paternity in men having CF
Case Respiratory
disease
Gastrointestinal
disease
PI Sweat
test
Age at
onset
Age at
diagnosis
1 Severe Severe Yes Positive 40 years 64 years
2 ? ? ? Positive ‘‘Proven C
3 Classicala Classicala ? Positive 31 yearsb
4 Moderate Yes ? Positive 4 years 21 years
5 Severe Yes Positive 31 yearsc
6 Moderate No ? Positive 21 years 19 years
7 Mild No Yes? Positive 30 years 32 years
8 Moderate No No Positive 30 years
9 Severe No No Normal 29 years 40 years
10 Absence No No Normal Meconium
ileus
36 years
a Postmortem examination.
b Age at death.
c Died age unknown.years. A girl became fatherless at the age of 35.9 years. Her
father carried the F508del/unknown genotype and was
diagnosed at the age of 61.8 years, less that 1 year before
dying. If excluding this particular case, the mean age of
children when their fathers died is 6.1 years. The proportion
of orphan in the registered population is over 10%. As a
comparison, in France, in 1999, only 2.1% of the children
were fatherless before the age of 21 years [16]. The relative
risk of becoming fatherless when the father is CF is
statistically increased (RR = 5.2, 95% CI: 2.4–11.2,
p <0.0001).
Few cases of natural fathering have been described in
men having proven CF (Table 3). Of the 10 cases found in
the literature, 2 were brothers (cases 2 and 3). All men but
2 (numbers 1 and 3) appeared to have a moderate form of
pulmonary disease. Few men had gastrointestinal disease
problems, including pancreatic insufficiency. All but
numbers 9 and 10 had ‘‘positive’’ sweat tests. Diagnosis
of CF of case number 10 can be discussed. Indeed, he had
meconium ileus with a normal pancreatic function and a
questionable genotype. In most cases, the mean age at
diagnosis was higher than the mean age at birth. Six semen
analyses were performed: 5 were normal, and 1 too thick.
No man had paternity testing, only ABO and Rhesus typing
were done with results consistent with paternity (numbers 4
and 6). Men numbers 8, 9 and 10 had CFTR gene analyses;
results were also coherent for paternity, except for the third
child of number 9, who carried no CFTR gene mutation
[17–25].
In the present study, no data were available on the
truthfulness of natural conceptions nor on the genetic status
of the children’s mothers.
Boyd et al. evaluated the fertility and pregnancy out-
comes of men and women with cystic fibrosis within a large
British cohort using the UK Cystic Fibrosis Database. Few
individuals sought fertility treatment (1% men, 0.5%
women) or achieved pregnancies (1.3% of partners of
men, 5.7% women). They concluded that optimal adultAge at
birth
Sperm
analysis
Number of
children
Genotype Reference
5 [18]
F’’ 3 [17]
4 [17]
29 years Normal 1 [19]
1 [20]
21 years Normal 2 [22]
Normal 1 [21]
Thick 1 F508del/- [23]
<30 years Normal 2 or 3 3849+10 kbC>T
homoz
[24]
35 years Normal 1 F508del/-9t/7t [25]
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men and women [26].
Fertility, infertility, practical and ethical aspects of ART
and parenthood have to be approached and discussed with
the patient and his partner by the whole care giving team.
De Braekeleer et al. investigated the level of disease
knowledge in adults and teenagers CF patients. More than
60% of teenagers and 86.2% of adult knew that male
infertility could be a manifestation of CF. Surprisingly, only
less than 10% of the nurses knew about it vs. 2/3 of the
specialists practitioners or of the parents of CF children
[27]. Sawyer et al. also reported reproductive knowledge
and attitudes of CF males. Ninety percent of them knew
that most of the CF males were infertile, and they first
heard about it from the care provider during teenagers.
They reported no more stress and accepted it as ‘‘part of
CF,’’ but only 1/3 had had semen analysis to establish their
fertility status. Only 50% of the parents knew that CF
males may be infertile, but only 1/10 thought they had
enough knowledge to talk about it with their child [28].
Patients also reported that they were told too late about the
link between CF and reduced fertility. They would have
preferred to be informed at the age of 14 years ( p <0.001).
They also expected more information on reproductive
options and 85% planned to have children [29]. Finally,
Fair et al. showed that CF adult patients confer a high
importance on issues on fertility and parenting. Data were
requested from patients, even if the subject appeared to be
difficult, especially for them [30].6. Conclusion
The present study offers a large complete clinical
description of CF men having paternity responsibility over
children. They did not significantly differ from the CF male
population of similar age. Their clinical status was overall
satisfactory and the presence of a child did not seem to have
either a positive or a negative impact on the disease course
and management. Considering that male infertility is an
inevitable component of CF and that ART is available, the
feasibility of having a child has to be discussed between the
CF patients and the multidisciplinary CF team. However,
the possible premature death and its consequence for the
family have to be taken into account with the patient and his
family according to his current clinical status.Acknowledgements
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